Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction chemotherapy before concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
ChiCTR-TRC-13003378Phase 2Completed
- Sponsor
- General Hospital of Central Theater Command Tumor Center
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cisplatin and fluorouracil in nasopharyngeal carcinoma (NPC) (2 arms), sponsored by General Hospital of Central Theater Command Tumor Center. Primary endpoints: Response rate after comprehensive treatment and Acute toxicity reaction. Started Mar 2013; status: completed.
02
Drugs
cisplatinfluorouracil
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on ChiCTR-TRC-13003378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003378.